Wolf Greenfield Welcomes Shareholder Michael Twomey to Biotechnology Group
We are pleased to announce that Michael J. Twomey has joined the firm as a shareholder. A skilled counselor to biotechnology and life sciences companies, Michael brings extensive experience in patent prosecution and portfolio development, patent licensing, and post-grant proceedings.
For more than 25 years, Michael has counseled clients in all aspects of domestic and foreign patent prosecution, as well as patent portfolio management and development. He is skilled in negotiation of patent licenses and the conduct of IP due diligence analyses in connection with mergers, acquisitions, public offerings and venture capital financings. He also provides clients with opinions relating to issues of patent infringement and validity, and conducts clearance studies and freedom-to-operate opinions for new product development and launches.
In addition, Michael has experience in U.S. Patent Office post-grant proceedings, including inter partes reviews (IPRs), inter partes reexams and ex parte reexams; appeals before the U.S. Board of Patent Appeals and Interferences, and the Court of Appeals for the Federal Circuit; oppositions before the European Patent Office; and U.S. district court patent litigation.
Michael was recommended in the 2016 edition of The Legal 500 United States for intellectual property: patents: portfolio management and licensing, and was recognized as a "Life Sciences Star" for outstanding intellectual property work in the 2012-2016 editions of LMG Life Sciences. He previously served as a partner at the law firm WilmerHale after beginning his career as an associate at Wolf Greenfield.
“We are excited to welcome Michael back to the firm,” said Tim Oyer, president and managing partner of Wolf Greenfield. “As an accomplished counselor and intellectual property strategist, he will add significant value for our clients.”
“Michael has broad knowledge of life sciences companies, from startups to multinational corporations,” said John Van Amsterdam, chair of Wolf Greenfield’s Biotechnology Group. “He knows how to let business needs guide intellectual property strategy, which is a longstanding focus for our firm.”
“I am pleased to be joining Wolf Greenfield’s outstanding life sciences team,” said Michael. “As one of the leading intellectual property law firms in New England, Wolf Greenfield’s strong reputation and commitment to clients is evident, and I look forward to contributing to the firm’s success.”
Michael is a graduate of Harvard Law School, and received his Bachelor of Arts in biological sciences from Harvard College. He was a National Science Foundation Graduate Fellow in biology from 1985 through 1988, and a Graduate Fellow in the Department of Biological Sciences at Stanford University from 1985 to 1990, where he conducted research in population genetics relating to the evolution of mutation and recombination rates.